| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,450.00
Est. +14%
|
$1,273.46 | $1,449.68 |
Bullseye Hit (±1%)
|
$1,417.83
+11.3%
|
| Jul 27, 2026 |
Merck & Co Inc
MRK
|
SELL |
$105.00
Est. +21%
|
$132.34 | $126.22 (Low) |
Pending
|
$150.39
-13.6%
|
| Feb 11, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$160.00
Est. +3%
|
$155.45 | $175.65 |
Target Met
|
$174.48
+12.2%
|
| Dec 29, 2025 |
Gilead Sciences, Inc.
GILD
|
BUY |
$135.00
Est. +8%
|
$124.56 | $175.65 |
Target Met
|
$174.48
+40.1%
|
| Oct 31, 2025 |
Pfizer Inc.
PFE
|
BUY |
$30.00
Est. +23%
|
$24.45 | $30.67 |
Precision Hit (±3%)
|
$30.79
+25.9%
|
| Dec 02, 2024 |
Merck & Co Inc
MRK
|
BUY |
$110.00
Est. +9%
|
$100.69 | $105.84 |
Miss
|
$150.39
+49.4%
|
| Oct 17, 2024 |
Moderna Inc
MRNA
|
SELL |
$55.00
Est. +4%
|
$57.46 | $23.15 (Low) |
Target Met
|
$258.38
-349.7%
|
| Oct 17, 2024 |
Abbvie Inc
ABBV
|
BUY |
$203.00
Est. +7%
|
$190.46 | $244.81 |
Target Met
|
$294.90
+54.8%
|
| Oct 17, 2024 |
Pfizer Inc.
PFE
|
BUY |
$32.00
Est. +8%
|
$29.67 | $29.50 |
Miss
|
$30.79
+3.8%
|